Phenylketonuria Treatment Consortium

The Phenylketonuria Treatment Consortium is a group of healthcare professionals and researchers dedicated to improving care for people with phenylketonuria (PKU), a genetic disorder that affects how the body processes an amino acid called phenylalanine. Their goal is to develop better treatment strategies, share knowledge, and support patients and families. By collaborating across specialties, they aim to enhance diagnosis, management, and long-term health outcomes for those affected by PKU, ultimately working towards personalized and effective therapies.